Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 05 Jun 2024 23:44:30 +0200Fri, 05 Apr 2024 17:02:00 +0200Perjeta : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2547_en_1.pdfPerjeta : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2547_en_1.pdfFri, 05 Apr 2024 17:02:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/perjetaHuman medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/perjetaFri, 05 Apr 2024 16:13:00 +0200Human medicine